GO:1904018 positive regulation of vasculature development: Angiogenesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904018 (positive regulation of vasculature development) describes any biological process that activates or increases the frequency, rate or extent of vasculature development, a core mechanism in angiogenesis and vessel remodeling.
• Endothelial Notch signaling is a canonical driver of angiogenesis and couples vessel formation to osteogenesis in bone, illustrating how positive regulation of vasculature development coordinates organ growth.
• Endothelial GATA4 acts as a gatekeeper that prevents a pathogenic switch in angiocrine signaling, thereby controlling liver fibrosis and regeneration.
• Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and enhances antitumor immunity, linking innate immune signaling to positive regulation of vasculature development.
• Ischemia is a classic physiological trigger of angiogenesis, and understanding ischemia-driven angiogenesis is central to therapeutic revascularization strategies.
• Tumor angiogenesis is a hallmark of cancer progression, and positive regulators of vasculature development are therefore high-value targets for oncology research.
Description
GO:1904018, positive regulation of vasculature development, is a Gene Ontology biological process term that captures any process which activates or increases the frequency, rate or extent of vasculature development. Vasculature development encompasses the formation, remodeling and maturation of blood vessel networks, and its positive regulation is essential for embryonic growth, tissue repair and organ homeostasis. Dysregulated positive regulation of vasculature development contributes to pathological conditions ranging from tumor angiogenesis to fibrosis and ischemic disease. In bone, endothelial Notch activity promotes angiogenesis and osteogenesis, demonstrating that positive regulation of vasculature development is tightly coupled to skeletal development. In the liver, endothelial GATA4 controls fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling, showing that positive regulators of vasculature development can also act as protective gatekeepers. Recent work has revealed that endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity, expanding the mechanistic repertoire of positive regulation of vasculature development into innate immune signaling. Ischemia-driven angiogenesis remains a paradigmatic example of physiological positive regulation of vasculature development, where hypoxia and metabolic stress trigger new vessel growth. Because positive regulation of vasculature development is central to both normal physiology and multiple diseases, researchers require robust experimental models to dissect its genetic and molecular control.
positive regulation of vasculature development At A Glance
| GO ID | GO:1904018 |
|---|---|
| GO term | positive regulation of vasculature development |
| Ontology | biological_process |
| Synonym | activation of vascular system development; activation of vasculature development; positive regulation of vascular system development; up regulation of vascular system development; up-regulation of vascular system development; upregulation of vascular system development; up regulation of vasculature development; up-regulation of vasculature development; upregulation of vasculature development |
| Major function | Activates or increases the frequency, rate or extent of vasculature development, including pro-angiogenic signaling and vessel remodeling |
| Representative regulators | Endothelial Notch, GATA4, STING-JAK1, and hypoxia-driven angiogenic programs |
| Physiological contexts | Embryonic development, bone formation, liver regeneration, ischemia-driven angiogenesis |
| Pathological contexts | Tumor angiogenesis, fibrosis, and immune-vascular crosstalk |
What Is GO:1904018?
According to the QuickGO definition, GO:1904018 positive regulation of vasculature development refers to any process that activates or increases the frequency, rate or extent of vasculature development. In other words, it is the positive arm of the regulatory network that governs how blood vessels form, expand and remodel. This term is a biological process and includes synonyms such as activation of vascular system development, activation of vasculature development, positive regulation of vascular system development, up regulation of vascular system development, up-regulation of vascular system development, upregulation of vascular system development, up regulation of vasculature development, up-regulation of vasculature development, and upregulation of vasculature development. Functionally, positive regulation of vasculature development encompasses pro-angiogenic signaling, endothelial cell activation, sprouting, vessel stabilization and normalization, as illustrated by endothelial Notch, GATA4 and STING-JAK1 pathways.
Why Is positive regulation of vasculature development Important in Cell Biology?
Positive regulation of vasculature development is fundamental because it governs how tissues acquire and maintain a functional blood supply, a prerequisite for oxygen and nutrient delivery in development, repair and regeneration. When this process is excessive or aberrant, it drives tumor angiogenesis and contributes to cancer progression, making it a major therapeutic target. Conversely, insufficient positive regulation of vasculature development underlies ischemic injury and impaired wound healing, motivating efforts to promote therapeutic angiogenesis. The discovery that endothelial Notch activity promotes angiogenesis and osteogenesis in bone highlights the importance of positive regulation of vasculature development for skeletal health. Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling, showing that positive regulators of vasculature development can protect organ function. Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity, revealing that positive regulation of vasculature development can be harnessed to improve immunotherapy. Thus, understanding positive regulation of vasculature development is essential for both mechanistic biology and translational medicine.
• Drives physiological angiogenesis required for embryonic development and organ growth.
• Supports bone formation by coupling endothelial Notch activity to osteogenesis.
• Protects the liver by preventing a pathogenic switch in angiocrine signaling via endothelial GATA4.
• Promotes tumor vasculature normalization and antitumor immunity through endothelial STING-JAK1 interaction.
• Is a hallmark of tumor angiogenesis and a target for anti-angiogenic cancer therapy.
• Mediates ischemia-driven angiogenesis, relevant to cardiovascular and peripheral artery disease.
• Influences immune cell infiltration in tumors and endometrial cancer.
• Provides mechanistic insight into fibrosis and tissue regeneration.
• Serves as a paradigm for studying endothelial cell signaling and vessel remodeling.
• Underpins therapeutic strategies for revascularization and regenerative medicine.
What Happens During positive regulation of vasculature development?
Initiation by pro-angiogenic signals
In simple terms: The process starts when cells receive signals telling them to grow new blood vessels.
Positive regulation of vasculature development is initiated by pro-angiogenic cues such as hypoxia and metabolic stress, which are classic triggers of ischemia-driven angiogenesis. In tumors, neoplastic angiogenesis is driven by a shift toward pro-angiogenic factor production, a hallmark of cancer progression. These initiating signals activate endothelial cells and set the stage for sprouting and vessel formation.
Endothelial Notch signaling and sprouting
In simple terms: Notch signaling acts like a traffic controller that tells some endothelial cells to lead new vessel sprouts.
Endothelial Notch activity promotes angiogenesis and osteogenesis in bone, demonstrating that Notch signaling is a core positive regulator of vasculature development. This pathway coordinates endothelial cell fate decisions during sprouting and couples vessel formation to bone formation. The involvement of Notch illustrates how positive regulation of vasculature development integrates with organ-specific developmental programs.
Angiocrine signaling and organ homeostasis
In simple terms: Endothelial cells release signals that keep organs healthy, and GATA4 prevents these signals from turning harmful.
Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling. This shows that positive regulation of vasculature development includes mechanisms that maintain a healthy angiocrine balance rather than simply increasing vessel number. When this control fails, a pathogenic switch can promote fibrosis, highlighting the dual role of positive regulators in homeostasis and disease.
Immune-vascular crosstalk and vessel normalization
In simple terms: Immune signals inside endothelial cells can make tumor blood vessels healthier and help the immune system fight cancer.
Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity. This finding places innate immune signaling within the positive regulation of vasculature development network and shows that vessel normalization can enhance antitumor immunity. It also connects positive regulation of vasculature development to immune cell infiltration in tumors.
Vessel stabilization and maturation
In simple terms: New vessels must be stabilized so they do not leak and can carry blood properly.
After sprouting, positive regulation of vasculature development includes steps that stabilize and mature vessels, as implied by the normalization phenotype observed with endothelial STING-JAK1 interaction. Proper stabilization is essential for functional perfusion and for avoiding pathological leakiness. This maturation phase is a key component of the overall positive regulation of vasculature development process.
Key Genes Involved in GO:1904018 positive regulation of vasculature development
The following genes and proteins are representative positive regulators of vasculature development, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOTCH (endothelial Notch signaling) | Promotes angiogenesis and osteogenesis in bone | Model for studying Notch-driven positive regulation of vasculature development |
| GATA4 | Controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling | Target for liver fibrosis and regeneration studies |
| STING | Interacts with JAK1 to promote tumor vasculature normalization and antitumor immunity | Target for tumor vasculature normalization and immunotherapy research |
| JAK1 | Partners with STING in endothelial cells to normalize tumor vasculature | Target for immune-vascular crosstalk studies |
| B7-H3 (CD276) | Immunoexpression in endometrial cancer relates to T-cell infiltration and prognosis | Marker for immune-vascular interactions in endometrial cancer |
| Hypoxia-inducible factors (HIFs) | Mediate ischemia-driven angiogenesis | Model for hypoxia-driven positive regulation of vasculature development |
| VEGF pathway components | Central pro-angiogenic signaling in neoplastic angiogenesis | Target for anti-angiogenic cancer research |
| Endothelial cell adhesion molecules | Support sprouting and vessel stabilization | Model for endothelial activation studies |
| Notch ligands (e.g., DLL4) | Regulate endothelial sprouting decisions | Target for angiogenesis modulation |
| Angiocrine factors | Mediate endothelial-organ crosstalk | Model for organ regeneration studies |
| STING pathway adaptors | Transduce innate immune signals in endothelium | Target for vessel normalization |
| JAK-STAT signaling components | Downstream of STING-JAK1 interaction | Model for immune-vascular signaling |
| Tumor angiogenesis drivers | Promote neoplastic angiogenesis | Target for oncology drug discovery |
| Ischemia-responsive genes | Drive revascularization after ischemic injury | Model for therapeutic angiogenesis |
| Immune checkpoint molecules | Modulate T-cell infiltration in tumors | Target for combined anti-angiogenic immunotherapy |
How Is positive regulation of vasculature development Regulated?
Positive regulation of vasculature development is controlled by multiple signaling inputs. Endothelial Notch activity acts as a positive regulator of angiogenesis and osteogenesis, indicating that Notch signaling is a key upstream control node. Endothelial GATA4 prevents a pathogenic switch in angiocrine signaling, thereby restraining fibrosis and supporting regeneration, which shows that positive regulation of vasculature development is subject to transcriptional gatekeeping. Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity, demonstrating that innate immune signaling can positively regulate vessel development and normalization. Ischemia-driven angiogenesis is regulated by hypoxia and metabolic stress, which are classic physiological triggers of positive regulation of vasculature development. In tumors, neoplastic angiogenesis is regulated by a shift in the balance of pro- and anti-angiogenic factors, a hallmark of cancer. Immune context also modulates this process, as B7-H3 immunoexpression in endometrial cancer relates to tumor T-cell infiltration and prognosis.
positive regulation of vasculature development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STING | Tumor vasculature normalization and antitumor immunity | Endothelial-specific knockout or knock-in in tumor models |
| JAK1 | Immune-vascular crosstalk in tumors | Point-mutation or knockout endothelial cell lines |
| GATA4 | Liver fibrosis and regeneration | Liver endothelial knockout or overexpression models |
| NOTCH | Bone angiogenesis and osteogenesis | Endothelial Notch gain- and loss-of-function models |
| B7-H3 (CD276) | Endometrial cancer prognosis and T-cell infiltration | Overexpression or knockout in endometrial cancer cell lines |
Cancer and tumor angiogenesis
Positive regulation of vasculature development is a hallmark of tumor angiogenesis, where neoplastic cells drive new vessel formation to support growth and metastasis. Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity, suggesting that modulating positive regulation of vasculature development can improve immunotherapy outcomes. B7-H3 immunoexpression in endometrial cancer relates to tumor T-cell infiltration and prognosis, linking immune-vascular interactions to clinical outcome.
Liver fibrosis and regeneration
Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling. This demonstrates that positive regulation of vasculature development can be protective when properly controlled, and that its dysregulation contributes to fibrotic disease.
Ischemic disease and revascularization
Ischemia-driven angiogenesis is a physiological example of positive regulation of vasculature development, and impaired revascularization underlies ischemic tissue injury. Understanding these mechanisms is essential for developing therapeutic angiogenesis strategies.
Bone development and skeletal disease
Endothelial Notch activity promotes angiogenesis and osteogenesis in bone, coupling positive regulation of vasculature development to skeletal health. Disruption of this coupling may contribute to bone disorders, making it a relevant area for musculoskeletal research.
From positive regulation of vasculature development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce positive regulation of vasculature development? | Knockout endothelial cell line or animal model |
| Does a specific point mutation alter pro-angiogenic signaling? | Point-mutation knock-in cell model |
| Does tagging a protein reveal its localization during vessel sprouting? | Tagged knock-in endothelial cells |
| Does overexpression of a pro-angiogenic factor increase vessel formation? | Overexpression cell model |
| Which genes are required for tumor vasculature normalization? | CRISPR library screening in endothelial cells |
| How does ischemia drive angiogenesis? | Ischemia-driven angiogenesis model |
How to Study the positive regulation of vasculature development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes in endothelial cells | Identify pro-angiogenic gene programs |
| Tube formation assay | Endothelial network formation in vitro | Measure positive regulation of vasculature development |
| Sprouting assay | Endothelial sprouting capacity | Study Notch-driven angiogenesis |
| In vivo tumor vasculature imaging | Vessel normalization and perfusion | Evaluate STING-JAK1 effects |
| Immunohistochemistry | B7-H3 expression and T-cell infiltration | Endometrial cancer prognosis studies |
| Ischemia model | Revascularization after ischemic injury | Study ischemia-driven angiogenesis |
| CRISPR library screening | Genes required for vessel formation | Discover novel regulators |
| Angiocrine factor profiling | Endothelial-derived secreted factors | Study liver fibrosis and regeneration |
Transcriptomic profiling of endothelial cells
RNA-seq can be used to identify genes whose expression changes during positive regulation of vasculature development, such as angiocrine factors controlled by GATA4. This approach helps map the transcriptional landscape of pro-angiogenic signaling.
Functional angiogenesis assays
Endothelial tube formation, sprouting and migration assays are standard methods to measure positive regulation of vasculature development in vitro. These assays can be combined with genetic perturbation to test causality.
In vivo vessel imaging
Imaging of tumor vasculature normalization and bone angiogenesis can reveal how positive regulation of vasculature development affects vessel structure and function. Such studies are essential for translating in vitro findings to whole organisms.
Immune-vascular crosstalk analysis
Assessing T-cell infiltration alongside vessel normalization provides insight into how positive regulation of vasculature development influences antitumor immunity. This is particularly relevant for endometrial cancer and other tumors.
How CRISPR Can Be Used to Study GO:1904018 positive regulation of vasculature development
Knockout
CRISPR knockout of candidate genes such as GATA4 or STING in endothelial cells can test whether they are required for positive regulation of vasculature development. Loss-of-function models help establish causality in angiogenesis assays.
Point Mutation
Point-mutation knock-in can be used to dissect specific phosphorylation or interaction sites, for example within the STING-JAK1 axis, to determine their role in vessel normalization. This approach refines mechanistic understanding beyond simple knockout.
Knock-in
Tagged knock-in of endothelial genes allows visualization of protein localization during sprouting and vessel maturation. Knock-in reporters can also track angiocrine signaling in live tissues.
Overexpression
Overexpression of pro-angiogenic factors or constitutively active signaling components can drive positive regulation of vasculature development and model pathological angiogenesis. This is useful for testing sufficiency in vessel formation.
How EDITGENE Supports positive regulation of vasculature development Research
Researchers studying positive regulation of vasculature development-related genes often need to determine whether a candidate gene is causally involved in endothelial sprouting, vessel normalization or angiocrine signaling. EDITGENE provides the CRISPR tools and cell models required to move from correlation to causation in this pathway.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of vasculature development research.
Frequently Asked Questions About positive regulation of vasculature development
What is GO:1904018 positive regulation of vasculature development?
GO:1904018 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of vasculature development.
What genes are involved in positive regulation of vasculature development?
Representative genes include endothelial Notch components, GATA4, STING, JAK1 and B7-H3, based on published studies.
How is positive regulation of vasculature development related to cancer?
It is a hallmark of tumor angiogenesis, where neoplastic cells drive new vessel formation to support growth and metastasis.
What is the role of endothelial Notch in vasculature development?
Endothelial Notch activity promotes angiogenesis and osteogenesis in bone, acting as a positive regulator of vessel formation.
How does GATA4 regulate liver fibrosis and regeneration?
Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling.
What is the role of STING-JAK1 interaction in tumor vasculature?
Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity.
What is ischemia-driven angiogenesis?
Ischemia-driven angiogenesis is a physiological example of positive regulation of vasculature development triggered by ischemic conditions.
How can CRISPR be used to study positive regulation of vasculature development?
CRISPR knockout, point mutation, knock-in and overexpression models can test the causal role of candidate genes in endothelial sprouting and vessel normalization.
What experimental models are used to study positive regulation of vasculature development?
Common models include endothelial cell lines, tumor vasculature models, bone angiogenesis models and ischemia models.
Why is positive regulation of vasculature development important for immunotherapy?
Vessel normalization driven by positive regulation of vasculature development can enhance antitumor immunity and T-cell infiltration.
Conclusion
GO:1904018 positive regulation of vasculature development is a central biological process that governs how blood vessels form, remodel and stabilize. Its regulation by endothelial Notch, GATA4 and STING-JAK1 pathways illustrates the diversity of mechanisms that control angiogenesis in development, homeostasis and disease. Because this process is implicated in cancer, fibrosis, ischemia and bone biology, it remains a high-priority area for mechanistic and translational research. CRISPR-based models and bioinformatics tools from EDITGENE can accelerate the discovery of causal regulators within this pathway.
References
- 2. Winkler M et al.. 2021. Endothelial GATA4 controls liver fibrosis and regeneration by preventing a pathogenic switch in angiocrine signaling.. J Hepatol 74(2):380-393 PMID: 32916216
- 3. Ramasamy SK et al.. 2014. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone.. Nature 507(7492):376-380 PMID: 24647000
- 4. Zhang H et al.. 2025. Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity.. J Clin Invest 135(2) PMID: 39817453
- 5. Fidler IJ. 2001. Regulation of neoplastic angiogenesis.. J Natl Cancer Inst Monogr PMID: 11158201
- 6. Voravud N et al.. 1999. Tumor angiogenesis.. J Med Assoc Thai 82(4):394-404 PMID: 10410503
- 7. Dor Y et al.. 1997. Ischemia-driven angiogenesis.. Trends Cardiovasc Med 7(8):289-94 PMID: 21235898
- 8. Brunner A et al.. 2012. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.. Gynecol Oncol 124(1):105-11 PMID: 21982044
